These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 10078118)
1. Prevalence of the factor VLeiden mutation among autopsy patients with pulmonary thromboembolic disease using an improved method for factor VLeiden detection. Gorman TE; Arcot AN; Baker P; Prior TW; Brandt JT Am J Clin Pathol; 1999 Mar; 111(3):413-7. PubMed ID: 10078118 [TBL] [Abstract][Full Text] [Related]
2. [Activated protein C resistance and venous thrombophilia: molecular genetic prevalence study in the German population]. Ehrenforth S; Klinke S; von Depka Prondzinski M; Kreuz W; Ganser A; Scharrer I Dtsch Med Wochenschr; 1999 Jun; 124(25-26):783-7. PubMed ID: 10414227 [TBL] [Abstract][Full Text] [Related]
3. A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism. Middeldorp S; Meinardi JR; Koopman MM; van Pampus EC; Hamulyák K; van Der Meer J; Prins MH; Büller HR Ann Intern Med; 2001 Sep; 135(5):322-7. PubMed ID: 11529695 [TBL] [Abstract][Full Text] [Related]
4. An overlooked factor VLeiden autopsy study. Dunn ST Am J Clin Pathol; 2000 Apr; 113(4):595-6. PubMed ID: 10761465 [No Abstract] [Full Text] [Related]
5. Factor V Leiden and the risk for venous thromboembolism in the adult Danish population. Juul K; Tybjaerg-Hansen A; Schnohr P; Nordestgaard BG Ann Intern Med; 2004 Mar; 140(5):330-7. PubMed ID: 14996674 [TBL] [Abstract][Full Text] [Related]
7. Phenotype and genotype expression in pseudohomozygous factor VLEIDEN : the need for phenotype analysis. Kalafatis M; Bernardi F; Simioni P; Lunghi B; Girolami A; Mann KG Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):336-42. PubMed ID: 9974416 [TBL] [Abstract][Full Text] [Related]
8. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism. Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312 [TBL] [Abstract][Full Text] [Related]
9. ARMS test for diagnosis of factor VLeiden mutation, a common cause of inherited thrombotic tendency. Yandava CN; Zappulla DC; Korf BR; Neufeld EJ J Clin Lab Anal; 1996; 10(6):414-7. PubMed ID: 8951612 [TBL] [Abstract][Full Text] [Related]
10. Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis. Simioni P; Prandoni P; Lensing AW; Manfrin D; Tormene D; Gavasso S; Girolami B; Sardella C; Prins M; Girolami A Blood; 2000 Nov; 96(10):3329-33. PubMed ID: 11071624 [TBL] [Abstract][Full Text] [Related]
11. Testing for factor V Leiden in patients with pulmonary or venous thromboembolism: a cost-effectiveness analysis. Eckman MH; Singh SK; Erban JK; Kao G Med Decis Making; 2002; 22(2):108-24. PubMed ID: 11958494 [TBL] [Abstract][Full Text] [Related]
12. Prothrombin gene mutation uncommon in pulmonary embolism. Kohlmeier RE; Cho CG; Bux RC; Guerra L; Rulon JJ; Selby DM; Gulley ML South Med J; 2000 Nov; 93(11):1073-7. PubMed ID: 11095555 [TBL] [Abstract][Full Text] [Related]
13. The epidemiology of venous thromboembolism in Caucasians and African-Americans: the GATE Study. Dowling NF; Austin H; Dilley A; Whitsett C; Evatt BL; Hooper WC J Thromb Haemost; 2003 Jan; 1(1):80-7. PubMed ID: 12871543 [TBL] [Abstract][Full Text] [Related]
14. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. Ridker PM; Miletich JP; Hennekens CH; Buring JE JAMA; 1997 Apr 23-30; 277(16):1305-7. PubMed ID: 9109469 [TBL] [Abstract][Full Text] [Related]
15. Do heterozygous factor V Leiden and prothrombin G20210A mutations have different impact on the type and location of venous thromboembolism? Chevalier Y; Mandrillon G; Bestion A; Lega JC; Piquet P; Ninet J; Dargaud Y Int Angiol; 2014 Aug; 33(4):404-5. PubMed ID: 25056173 [No Abstract] [Full Text] [Related]
16. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment. Salomon O; Steinberg DM; Zivelin A; Gitel S; Dardik R; Rosenberg N; Berliner S; Inbal A; Many A; Lubetsky A; Varon D; Martinowitz U; Seligsohn U Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):511-8. PubMed ID: 10073951 [TBL] [Abstract][Full Text] [Related]
17. Summaries for patients. Blood clots in people with the factor V Leiden mutation. Ann Intern Med; 2001 Sep; 135(5):S-34. PubMed ID: 11556288 [No Abstract] [Full Text] [Related]
18. Summaries for patients. Blood clots in people with factor V Leiden mutation. Ann Intern Med; 2004 Mar; 140(5):I50. PubMed ID: 14996692 [No Abstract] [Full Text] [Related]
19. Prevalence of factor V Leiden and prothrombin 20210 A variant in Bulgarian patients with pulmonary thromboembolism and deep venous thrombosis. Boyanovsky B; Russeva M; Ganev V; Penev M; Baleva M Blood Coagul Fibrinolysis; 2001 Dec; 12(8):639-42. PubMed ID: 11734663 [TBL] [Abstract][Full Text] [Related]
20. Coinheritance of factor V Leiden (F5 1691A) and prothrombin 20210 A (F2 20210A) in an Austrian family as cause for early onset of venous thromboembolism. Brodmann M; Renner W; Stark G; Ramschak H; Seinost G; Pilger E Thromb Res; 2001 Mar; 101(5):421-2. PubMed ID: 11421205 [No Abstract] [Full Text] [Related] [Next] [New Search]